Sectoral Asset Management’s Atea Pharmaceuticals AVIR Stock Holding History

Sectoral Asset Management’s Portfolio AVIR Stock Details AVIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-600,461	Closed	-$1.8M	–	108
2023 Q3	$1.8M	Buy	600,461 +98,924	+20%	+$337K	0.35%	87
2023 Q2	$1.88M	Buy	501,537 +120,687	+32%	+$452K	0.31%	90
2023 Q1	$1.28M	Buy	380,850 +99,447	+35%	+$403K	0.25%	90
2022 Q4	$1.35M	Buy	+281,403	New	+$1.42M	0.26%	87
2021 Q3	–	Sell	-538,884	Closed	-$11.6M	–	128
2021 Q2	$11.6M	Sell	538,884 -800,000	-60%	-$24M	0.94%	42
2021 Q1	$82.7M	Sell	1,338,884 -153,206	-10%	-$10.4M	6.27%	1
2020 Q4	$62.3M	Buy	+1,492,090	New	+$48.1M	4.39%	1

Other funds holding AVIR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Sectoral Asset Management's AVIR Position: Q4 2023 in Review

Sectoral Asset Management sold out of Atea Pharmaceuticals (AVIR) in Q4 2023, closing a stake of 600,461 shares — an estimated $1.8M sold.

Sectoral Asset Management first reported a position in AVIR in Q4 2020 and held it in 7 quarters. The position peaked at $82.7M in Q1 2021. 108 funds tracked by Wall St. Rank hold AVIR as of Q4 2023.

Sectoral Asset Management reported no remaining Atea Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
Sectoral Asset Management sold 600,461 Atea Pharmaceuticals shares in Q4 2023, an estimated $1.8M.
Sectoral Asset Management first reported a position in Atea Pharmaceuticals in Q4 2020 and held it in 7 quarters.
Sectoral Asset Management's Atea Pharmaceuticals position peaked at $82.7M in Q1 2021.
108 funds tracked by Wall St. Rank held Atea Pharmaceuticals as of Q4 2023.

Based on Sectoral Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.